The Latest Cardiac and Vascular News
As Demand for Cardiac EP Clinicians Expands New CE Series Offers Clinicians Flexible Learning Options NORTHFIELD, Ill., Aug. 23, 2021 /PRNewswire/ — Medline ReNewal today announced the launch of a continuing education (CE) course series to help cardiac electrophysiology (EP) clinicians learn more about the fundamentals of cardiac EP lab procedures. Available through Medline, […]
NEW YORK and DURHAM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) — Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination with Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company’s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The […]
Malmö, Sweden, August 23, 2021 Preliminary Dan-NICAD II results to be presented at ESC Acarix AB (publ) today announced that the preliminary results of the Dan-NICAD II study will be presented at the ESC congress on 27AUG2021. The Dan-NICAD II trial was initiated in January 2018 to assess non-invasive methods in patients referred to CCTA (Coronary Computed Tomography […]
VASCEPA found in prespecified and post hoc analyses to reduce first and total primary endpoints by 26% and 35%, respectively, in patients with prior Myocardial Infarction DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that data adding to the growing body […]
Rapid benefit of sotagliflozin supported by data from the SOLOIST and SCORED trials presented at ESC Congress 2021 – The Digital Experience, including: 33% absolute risk reduction in the composite cardiovascular endpoint in type 2 diabetes patients with acute decompensated heart failure (HF), with consistent results among patients with preserved […]
Nationally there is a trend moving towards radial artery access versus femoral artery access for endovascular procedures, and Q’Apel Medical is leading the way. FREMONT, Calif., Aug. 23, 2021 /PRNewswire/ — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today […]
International Study to Evaluate Innovative Minimally Invasive Treatment for Heart Failure With Early-Stage Functional Mitral Regurgitation KIRKLAND, Wash., Aug. 20, 2021 /PRNewswire/ — Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the launch of the U.S. […]
FRISCO, Texas, Aug. 20, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters in the United States and the European Union. The SKATER™ Mini-Loop is a drainage catheter placed through the skin using imaging guidance as a minimally invasive […]
WHITTIER, Calif., Aug. 19, 2021 /PRNewswire/ — PIH Health Good Samaritan Hospital has a new treatment option available for patients with severely calcified coronary artery disease. The new technology is a novel application of lithotripsy, sonic pressure waves or shockwave energy, which has been used for many years to safely break up kidney stones. […]
